155 related articles for article (PubMed ID: 32671985)
1. Inherited variant in NFκB-1 promoter is associated with increased risk of IBD in an Algerian population and modulates SOX9 binding.
Hamadou I; Garritano S; Romanel A; Naimi D; Hammada T; Demichelis F
Cancer Rep (Hoboken); 2020 Jun; 3(3):e1240. PubMed ID: 32671985
[TBL] [Abstract][Full Text] [Related]
2. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer.
Mohd Suzairi MS; Tan SC; Ahmad Aizat AA; Mohd Aminudin M; Siti Nurfatimah MS; Andee ZD; Ankathil R
Cancer Epidemiol; 2013 Oct; 37(5):634-8. PubMed ID: 23806437
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of NFκB1 and IκBα and Their Synergistic Effect on Nasopharyngeal Carcinoma Susceptibility.
Liu Y; Qiu F; Yang L; Yang R; Yang X; Huang D; Fang W; Zhang L; Jiang Q; Zhang L; Zhou Y; Lu J
Biomed Res Int; 2015; 2015():362542. PubMed ID: 26161396
[TBL] [Abstract][Full Text] [Related]
4. The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC.
Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S
Cancer Biomark; 2016; 16(1):109-15. PubMed ID: 26835711
[TBL] [Abstract][Full Text] [Related]
5. NFKB1 promoter -94 insertion/deletion ATTG polymorphism (rs28362491) is associated with severity and disease progression of rheumatoid arthritis through interleukin-6 levels modulation in Egyptian patients.
Elkhawaga SY; Gomaa MH; Elsayed MM; Ebeed AA
Clin Rheumatol; 2021 Jul; 40(7):2927-2937. PubMed ID: 33459954
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of NFκB1-94ins/delATTG and NFκBIA-881A/G genes in Egyptian patients with colorectal cancer.
Youssef MR; Attia ZI; El-Baz RA; Roshdy S; Settin A
Fam Cancer; 2017 Oct; 16(4):517-524. PubMed ID: 28389768
[TBL] [Abstract][Full Text] [Related]
7. The -94Ins/DelATTG polymorphism in NFκB1 promoter modulates chronic hepatitis C and liver disease progression.
Fakhir FZ; Lkhider M; Badre W; Alaoui R; Pineau P; Ezzikouri S; Benjelloun S
Infect Genet Evol; 2016 Apr; 39():141-146. PubMed ID: 26827631
[TBL] [Abstract][Full Text] [Related]
8. Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population.
Li P; Gu J; Yang X; Cai H; Tao J; Yang X; Lu Q; Wang Z; Yin C; Gu M
PLoS One; 2013; 8(8):e71604. PubMed ID: 23977085
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation and alterations of genes involved in NFκB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer.
Ungerbäck J; Belenki D; Jawad ul-Hassan A; Fredrikson M; Fransén K; Elander N; Verma D; Söderkvist P
Carcinogenesis; 2012 Nov; 33(11):2126-34. PubMed ID: 22843550
[TBL] [Abstract][Full Text] [Related]
10. The relationship between functional promoter -94 ins/del ATTG polymorphism in NF-κ B1 gene and the risk of urinary cancer.
Li X; Gao Y; Zhou H; Xu W; Li P; Zhou J; Xu T; Yu B; Xu Z; Zou Q; Yin C; Cai H; Shen W
Cancer Biomark; 2016; 16(1):11-7. PubMed ID: 26484607
[TBL] [Abstract][Full Text] [Related]
11. NFκB1 and NFκBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population.
Song S; Chen D; Lu J; Liao J; Luo Y; Yang Z; Fu X; Fan X; Wei Y; Yang L; Wang L; Wang J
PLoS One; 2011; 6(6):e21726. PubMed ID: 21738780
[TBL] [Abstract][Full Text] [Related]
12. Association of NFKB1 and NFKBIA polymorphisms in relation to susceptibility of Behçet's disease.
Yenmis G; Oner T; Cam C; Koc A; Kucuk OS; Yakicier MC; Dizman D; Kanigur Sultuybek G
Scand J Immunol; 2015 Jan; 81(1):81-6. PubMed ID: 25367031
[TBL] [Abstract][Full Text] [Related]
13. Functional polymorphisms in NFκB1/IκBα predict risks of chronic obstructive pulmonary disease and lung cancer in Chinese.
Huang D; Yang L; Liu Y; Zhou Y; Guo Y; Pan M; Wang Y; Tan Y; Zhong H; Hu M; Lu W; Ji W; Wang J; Ran P; Zhong N; Zhou Y; Lu J
Hum Genet; 2013 Apr; 132(4):451-60. PubMed ID: 23322360
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in oxidative pathway related genes and susceptibility to inflammatory bowel disease.
Senhaji N; Nadifi S; Zaid Y; Serrano A; Rodriguez DAL; Serbati N; Karkouri M; Badre W; Martín J
World J Gastroenterol; 2017 Dec; 23(47):8300-8307. PubMed ID: 29307990
[TBL] [Abstract][Full Text] [Related]
15. NFKB1 polymorphism is associated with age-related gene methylation in Helicobacter pylori-infected subjects.
Arisawa T; Tahara T; Shiroeda H; Yamada H; Nomura T; Hayashi R; Saito T; Fukuyama T; Otsuka T; Nakamura M; Toshikuni N; Tsuchishima M; Shibata T
Int J Mol Med; 2012 Aug; 30(2):255-62. PubMed ID: 22614238
[TBL] [Abstract][Full Text] [Related]
16. -94 ATTG insertion/deletion polymorphism of the NFKB1 gene is associated with coronary artery disease in Han and Uygur women in China.
Yang YN; Zhang JY; Ma YT; Xie X; Li XM; Liu F; Chen BD; Dong XH; Zheng YY; Pan S; Zhai H; Li DZ; Chen QJ
Genet Test Mol Biomarkers; 2014 Jun; 18(6):430-8. PubMed ID: 24818816
[TBL] [Abstract][Full Text] [Related]
17. A functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal cell carcinoma.
Cai H; Sun L; Cui L; Cao Q; Qin C; Zhang G; Mao X; Wang M; Zhang Z; Shao P; Yin C
Urol Int; 2013; 91(2):206-12. PubMed ID: 23295440
[TBL] [Abstract][Full Text] [Related]
18. Association of Pre-miRNA-499 rs3746444 and Pre-miRNA-146a rs2910164 Polymorphisms and Susceptibility to Behcet's Disease.
Oner T; Yenmis G; Tombulturk K; Cam C; Kucuk OS; Yakicier MC; Dizman D; Sultuybek GK
Genet Test Mol Biomarkers; 2015 Aug; 19(8):424-30. PubMed ID: 26053525
[TBL] [Abstract][Full Text] [Related]
19. Genetic association between NFKB1 -94 ins/del ATTG Promoter Polymorphism and cancer risk: a meta-analysis of 42 case-control studies.
Wang D; Xie T; Xu J; Wang H; Zeng W; Rao S; Zhou K; Pei F; Zhou Z
Sci Rep; 2016 Jul; 6():30220. PubMed ID: 27443693
[TBL] [Abstract][Full Text] [Related]
20. The Correlation of Increased CRP Levels with NFKB1 and TLR2 Polymorphisms in the Case of Morbid Obesity.
Soydas T; Karaman O; Arkan H; Yenmis G; Ilhan MM; Tombulturk K; Tasan E; Kanigur Sultuybek G
Scand J Immunol; 2016 Nov; 84(5):278-283. PubMed ID: 27507606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
